Related Experiment Video
Updated: Aug 8, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Multidrug-resistant Gram-negative Bacterial Bloodstream Infections in Children's Hospitals in Japan, 2010-2017
Yuta Aizawa1,2, Takayo Shoji3, Kenta Ito4
1From the Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Insights
Multidrug-resistant Gram-negative bacilli bloodstream infections (MDR GNB BSI) in children are linked to cancer chemotherapy and older age. MDR GNB BSI did not significantly increase mortality rates in this pediatric study.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Microbiology
- Hospital Epidemiology
Background:
- Multidrug-resistant Gram-negative bacilli bloodstream infections (MDR GNB BSI) pose a significant threat in pediatric healthcare settings.
- Risk factors and outcomes for MDR GNB BSI in children remain incompletely understood.
- This study addresses the knowledge gap regarding pediatric MDR GNB BSI.
Purpose of the Study:
- To identify risk factors associated with MDR GNB BSI in pediatric patients.
- To evaluate the clinical outcomes of children experiencing MDR GNB BSI.
- To compare MDR and non-MDR GNB BSI in a large cohort of children.
Main Methods:
- Retrospective analysis of clinical and microbiological data from 629 GNB BSI episodes across 8 Japanese children's hospitals (April 2010-March 2017).
- Comparison of risk factors and outcomes between multidrug-resistant (MDR) and non-multidrug-resistant (non-MDR) GNB BSI cases.
- Statistical analysis to determine independent associations with MDR GNB BSI.
Main Results:
- Multidrug-resistance (MDR) accounted for 24.5% of Gram-negative bacilli (GNB) bloodstream infections (BSI) in children, with no significant change over time.
- Effective initial empiric therapy coverage was lower for MDR GNB BSI (60.4%) compared to non-MDR GNB BSI (83.4%).
- Independent risk factors for MDR GNB BSI included recent cancer chemotherapy (OR 43.90), older age (OR 1.05), and neonatal ward admission (OR 0.019).
Conclusions:
- Approximately one-fourth of pediatric GNB BSI cases were multidrug-resistant.
- Cancer chemotherapy and older age are significant risk factors for developing MDR GNB BSI in pediatric hospitals.
- MDR GNB BSI was not found to independently increase the 28-day all-cause mortality rate in this pediatric cohort.
Background:
The risk factors of multidrug-resistant (MDR) Gram-negative bacilli (GNB) bloodstream infection (BSI) are not yet known in children. Our aim was to evaluate risk factors and outcomes associated with MDR GNB BSI in children.
Methods:
Patients with GNB BSI were enrolled between April 2010 and March 2017 at 8 children's hospitals in Japan. Clinical and microbiologic data were collected retrospectively. The risk factors and outcomes of MDR and non-MDR GNB BSI were compared.
Results:
In total, 629 GNB BSI episodes met the case definition. The median age and proportion of males were 2 years (interquartile range, 0.3-8.7) and 50.7%, respectively. An underlying disease was found in 94% of patients. The proportion of BSI cases that developed >48 hours after admission was 76.2%. MDR comprised 24.5% of BSI cases. The MDR rate did not change over time (P = 0.540). The effective coverage rate of the initial empiric therapy for the MDR and non-MDR BSI cases was 60.4% and 83.4%, respectively (P < 0.001). The all-cause mortality rate at 28 days for all BSI, MDR-BSI and non-MDR BSI cases was 10.7%, 13.6% and 9.7%, respectively (P = 0.167). MDR BSI was independently associated with cancer chemotherapy within 30 days (odds ratio [OR] 43.90), older age (OR 1.05) and admission to the neonatal ward (OR 0.019).
Conclusions:
One-fourth of GNB BSI cases were MDR. Cancer chemotherapy and older age were risk factors for MDR GNB BSI in children's hospitals. MDR did not increase the all-cause mortality rate.
More Related Videos
Related Concept Videos
Antibiotic Selection
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Bacterial Gastroenteritis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

